Multiple Myeloma Knowledge Hub

COMPARE CRUSH: Integral and Crushed Pills Same for TIMI Flow Post-PCI

TOURMALINE-MM2: Oral Ixazomib Combo for Transplant-Ineligible Multiple Myeloma

A study published in Blood evaluated outcomes of oral ixazomib with lenalidomide plus dexamethasone for the treatment of patients with newly diagnosed, transplant-ineligible multiple myeloma (MM). The TOURMALINE-MM2 trial was a double-blind, placebo-controlled study of...

Expert Interviews

Curated Journal reading List